Clinical Trial Update: Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating folic acid and vitamin B12 as potential interventions for schizophrenia. The update does not provide results, phase info…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Vitamin B12 (cobalamin)
• folic acid (folic acid)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Schizophrenia | NA | Status: UNKNOWN